Publicación:
Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin
Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin
No hay miniatura disponible
Fecha
2017
Autores
Gomes, C
Martinez-Puchol, S
Palma, N
Horna, G
Ruiz-Roldan, L
Pons, MJ
Ruiz, J
Título de la revista
Revista ISSN
Título del volumen
Editor
Society of Tropical Medicine and Hygiene
Proyectos de investigación
Unidades organizativas
Número de la revista
Abstracto
From its introduction in 1952 onwards, the clinical use of macrolides has been steadily increasing, both in human and veterinary medicine. Although initially designed to the treatment of Gram-positive microorganisms, this antimicrobial family has also been used to treat specific Gram-negative bacteria. Some of them, as azithromycin, are considered in the armamentarium against Enterobacteriaceae infections. However, the facility that this bacterial genus has to gain or develop mechanisms of antibiotic resistance may compromise the future usefulness of these antibiotics to fight against Enterobacteriaceae infections. The present review is focused on the mechanisms of macrolide resistance, currently described in Enterobacteriaceae.
Descripción
Palabras clave
Mutaciones ribosomales,
ARNr 23S,
Metilasas,
Esterasas,
Fosfotransferasas